Market open Closes in 5 hr 8 min
Prices delayed by at least 15 minutes | Prices updated on 21 May 2025, 11.06 BST | Print

Live UK pricing:

Hikma Pharmaceuticals PLC (HIK)

ORD SHS 10P
Sell: 2,086.00p|Buy: 2,088.00p|Change: 8.00 (0.39%)

Open 

2,068.00p


Previous close 

2,074.00p


Trade high 

2,106.00p


Volume 

67,653


Year high 

2,360.00p


Year low 

1,751.00p


Dividend yield 

2.96%


Market capitalisation 

£4.59 bn


P/E ratio 

17.21


ISIN 

GB00B0LCW083


Share price

Dividends

PreviousLatest
Record date16/08/202421/03/2025
Ex-dividend date15/08/202420/03/2025
Payment date20/09/202401/05/2025
Amount24.26p37.21p

Performance 20/05/2025

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Hikma Pharmaceuticals PLC+ 0.29
FTSE 100+ 0.94
More...

Company profile

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

Sector 

Healthcare


Recent trades

DateTimePriceQuantityValue (£)
21/05/202511:05:1420821944,039.08
21/05/202511:05:1420821092,269.38
21/05/202511:05:142082671,394.94
21/05/202511:05:142082911,894.62
21/05/202511:05:142082972,019.54

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.